Breakthroughs Podcast

0

Northwestern University Feinberg School of Medicine is a research-intensive medical school that fosters powerful collaborations on a thriving academic medical campus. We are driven by our mission to transform the practice of medicine and profoundly impact human health beyond the individual patient. We believe better answers only come from discovery.


Podcasts

It is the most common tumor found in women and is the cause of 200,000 hysterectomies in the United States every year. Yet, uterine fibroids have not been a frequent topic of medical research. Northwestern’s Serdar Bulun, MD, leads one of the few research programs focused on the molecular and cellular abnormalities that may cause uterine fibroids and is investigating novel targets to treat the condition.

For those with advanced metastatic prostate cancer, treatments are limited, but a new phase 3 international trial shows that a genetically targeted therapy could offer new hope for patients with specific gene mutations in their tumors. Northwestern's Maha Hussain, MD, recently presented the results of this landmark trial and shares her insight.

Northwestern scientists are conducting dozens of experiments and clinical trials aimed at understanding and fighting glioblastoma, the most common and aggressive primary brain tumor in adults. Rimas Lukas, MD, shares results of a promising Phase 1 clinical trial and other projects underway. 

Mozziyar Etemadi, MD, PhD, a research assistant professor in Anesthesiology and Biomedical Engineering, is leading deep learning projects in his lab at Northwestern. He talks about a collaboration between Northwestern and Google that uses a deep learning system to predict lung cancer.